InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporationverified

NVIVQ

Price:

$0.37

Market Cap:

$995.92K

InVivo Therapeutics Holdings Corp. is a U.S.-based biotechnology and biomaterials company, engaged in both research and clinical development. The company's primary focus is on pioneering and commercializing biopolymer scaffolding devices specifically designed for the treatment of spinal cord injuries (SCI). Its flagship product under development is the Neuro-Spinal Scaffold implant, which is constructed from a blend of biocompatible and bioresorbable polymers. These polymers include Poly lactic-co-glycolic acid (PLGA), a material frequently found in dissolvable sutures that provides crucial biocompatible support for the scaffold, and Poly-L-Lysine, a positively charged polymer used to encour...[Read more]

Industry

Biotechnology

IPO Date

2010-11-15

Stock Exchange

OTC

Ticker

NVIVQ

The Enterprise Value as of June 2026 (TTM) for InVivo Therapeutics Holdings Corporation (NVIVQ) is -14406082.00

According to InVivo Therapeutics Holdings Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is -14406082.00. This represents a change of 86.04% compared to the average of -7743505.00 of the last 4 quarters.

InVivo Therapeutics Holdings Corporation (NVIVQ) Historical Enterprise Value (quarterly & annually)

How has NVIVQ Enterprise Value performed in the past?

The mean historical Enterprise Value of InVivo Therapeutics Holdings Corporation over the last ten years is 53.67M. The current -14406082.00 Enterprise Value has changed -2784.00% with respect to the historical average. Over the past ten years (40 quarters), NVIVQ's Enterprise Value was at its highest in in the June 2015 quarter at 404.62M. The Enterprise Value was at its lowest in in the June 2018 quarter at -19785525.00.

Quarterly (TTM)
Annual

Average

53.67M

Median

5.40M

Minimum

-12881833.25

Maximum

171.96M

InVivo Therapeutics Holdings Corporation (NVIVQ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of InVivo Therapeutics Holdings Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 370.74%

Maximum Annual Enterprise Value = 171.96M

Minimum Annual Increase = -118.80%

Minimum Annual Enterprise Value = -12881833.25

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022-11791286.10370.74%
2021-2504821.00-80.56%
2020-12881833.25318.96%
2019-3074690.0022.88%
2018-2502277.50-118.80%
201713.31M-87.91%
2016110.06M-36.00%
2015171.96M63.77%
2014105.00M-37.93%
2013169.16M63.65%

InVivo Therapeutics Holdings Corporation (NVIVQ) Average Enterprise Value

How has NVIVQ Enterprise Value performed in the past?

The current Enterprise Value of InVivo Therapeutics Holdings Corporation (NVIVQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-9059313.45

5-year avg

-6550981.57

10-year avg

53.67M

InVivo Therapeutics Holdings Corporation (NVIVQ) Enterprise Value vs. Peers

How is NVIVQ’s Enterprise Value compared to its peers?

InVivo Therapeutics Holdings Corporation’s Enterprise Value is less than RegenETP, Inc. (0), less than Suvanza Pharma, LLC (0), less than Novation Companies, Inc. (90.28M), less than Entourage Health Corp. (151.97M), less than Asep Medical Holdings Inc (1.40M), less than Point of Care Nano-Technology, Inc. (727.41K), less than Digipath, Inc. (0), less than Nutroganics, Inc. (4.02M), less than Evolva Holding S.A. (4.15M), less than null (6.72M),

Build a custom stock screener for InVivo Therapeutics Holdings Corporation (NVIVQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InVivo Therapeutics Holdings Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InVivo Therapeutics Holdings Corporation (NVIVQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InVivo Therapeutics Holdings Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is InVivo Therapeutics Holdings Corporation's Enterprise Value?

What is the highest Enterprise Value for InVivo Therapeutics Holdings Corporation (NVIVQ)?

What is the 3-year average Enterprise Value for InVivo Therapeutics Holdings Corporation (NVIVQ)?

What is the 5-year average Enterprise Value for InVivo Therapeutics Holdings Corporation (NVIVQ)?

How does the current Enterprise Value for InVivo Therapeutics Holdings Corporation (NVIVQ) compare to its historical average?